Immune Response to AAV CRISPR Therapy for Duchenne Muscular Dystrophy

Time: 12:00 pm
day: Day 1 Tacks 1 AM

Details:

• Examining immunogenicity to AAV based CRISPR therapy
• Modelling immune response in DMD mode

Speakers: